Showing results (1391-1400 of 1,505) with videos related to
Sort By:
Pageof 151
Blood Cancer Discovery|October 18, 2021
Correction: COVID-19 Infections and Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic CentersMalin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.The Lancet. Haematology|May 28, 2021
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trialBenjamin Diamond, Neha Korde, Alexander M Lesokhin, et al.Blood Cancer Discovery|October 15, 2021
COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic CentersMalin Hultcrantz, Joshua Richter, Cara A Rosenbaum, et al.Blood|January 10, 2023
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signaturesBenjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, et al.Cell Death and Differentiation|July 23, 2016
ASPP2 deficiency causes features of 1q41q42 microdeletion syndromeJ Zak, V Vives, D Szumska, et al.Cell|June 25, 2021
Pharmacologic modulation of RNA splicing enhances anti-tumor immunitySydney X Lu, Emma De Neef, James D Thomas, et al.Cell Death and Differentiation|July 16, 2011
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012L Galluzzi, I Vitale, J M Abrams, et al.The New England Journal of Medicine|February 23, 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase InhibitorsEric Wang, Xiaoli Mi, Meghan C Thompson, et al.Cell|April 24, 2025
Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemiasWon Jun Kim, Edie I Crosse, Emma De Neef, et al.Physical Review Letters|March 15, 2024
Evidence for Chiral Wobbler in NucleiR J Guo, S Y Wang, C Liu, et al.Pageof 151